The Molecular Biology Society of Japan

[3P-0652] The development of drug screening system for dysferlinopathy using patient derived iPS cells

〇Yuko Kokubu1,3, Tomoko Nagino2,3, Katunori Sasa2,3, Tatsuo Oikawa2,3, Katsuya Miyake4, Mikiko Fukuda1,3, Ryuichi Tozawa2,3, Hidetoshi Sakurai1,3 (1.Center for iPS Cell Research and Application (CiRA), Kyoto University, 2.Regenerative Medicine Unit, Takeda Pharmaceutical company Ltd., 3.Takeda-CiRA joint program (T-CiRA) , 4.International University of Health and Welfare)

iPS, drug screening, skeletal muscle

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password